Breaking News

How to leverage the gut-skin axis to address health conditions

How to leverage the gut-skin axis to address health conditions

Food supplements: a better way to utilise the body’s microbiome? Stuart J. Ashman, CEO, and Dr Catherine O’Neill, CSO, SkinBioTherapeutics, investi...
DuPont enters microbiome therapy collaboration with MRM Health

DuPont enters microbiome therapy collaboration with MRM Health

MRM has raised more than $15m to advance its clinical and preclinical development programmes
Kaleido joins forces with Janssen on microbiome metabolic therapies

Kaleido joins forces with Janssen on microbiome metabolic therapies

Janssen and Kaleido have agreed to explore the potential of microbiome metabolic therapies to prevent onset of childhood allergy and other atopic,...
Exponential growth on the cards for the microbiome industry

Exponential growth on the cards for the microbiome industry

The microbiome market could be as big as biotech in the next 20 years, reports Dr Isabelle de Cremoux, CEO and Managing Partner, Seventure Partners
LNC Therapeutics forms advisory board for Christensenella research

LNC Therapeutics forms advisory board for Christensenella research

The gut microbiome-based drug research and discovery specialist has chosen experts to advise the future of its Christensella R&D programme
New microbiome specialist raises $82m and partners with Thermo Fisher

New microbiome specialist raises $82m and partners with Thermo Fisher

Arranta Bio will have access to Thermo Fisher’s full suite of products and services and will provide materials to Thermo Fisher for use in gene the...
Call to cut Indian child deaths from pneumonia and diarrhoea

Call to cut Indian child deaths from pneumonia and diarrhoea

Lack of access to life-saving treatment and prevention measures such as vaccination programmes is costing the lives of many Indian children
Tillotts signs IBD research agreement

Tillotts signs IBD research agreement

Discovery efforts with LabGenius to identify and develop new drug candidates for the treatment of inflammatory bowel diseases
Berberine enhances antibiotic treatment of Helicobacter pylori

Berberine enhances antibiotic treatment of Helicobacter pylori

Helicobacter pylori are Gram-negative bacteria that inhabit the gastric mucosa and are associated with peptic ulcers and gastric malignancy
Opioid-induced constipation – naloxegol

Opioid-induced constipation – naloxegol

About half of all patients taking opioids commonly experience constipation
Collaboration to develop novel microbial therapy for UC

Collaboration to develop novel microbial therapy for UC

Microbiotica has entered into an agreement with the University of Adelaide as part of its programme to develop a defined bacterial product for ulce...
Inflammatory bowel disease – vedolizumab

Inflammatory bowel disease – vedolizumab

Although Crohn’s disease and ulcerative colitis are the two most common forms of inflammatory bowel disease, treatment options remain less than ideal
Microbiotica enters into microbiome collaboration with Genentech

Microbiotica enters into microbiome collaboration with Genentech

Microbiotica, a leading player in microbiome-based therapeutics, has entered into a multi-year strategic collaboration with Genentech, a member of...
Obesity – lorcaserin

Obesity – lorcaserin

With the growing incidence of obesity there is a real need for pharmaceutical assistance for losing weight in patients who are unable (or unwilling...

In Brief

Therapeutic: cobitolimod for ulcerative colitis

Drug delivery solution for the treatment of gastrointestinal disorders

New room-temperature stable Carglunic acid tablets

RedHill Biopharma announces exclusive US co-promotion agreement with Concordia for GI drug Donnatal

Most Popular in Digestion

  1. Actavis appoints new managers for its US Specialty Brands business
  2. Therapeutic: cobitolimod for ulcerative colitis

Reports

Exponential growth on the cards for the microbiome industry
Exponential growth on the cards for the microbiome industry
Call to cut Indian child deaths from pneumonia and diarrhoea
Call to cut Indian child deaths from pneumonia and diarrhoea
Opioid-induced constipation – naloxegol
Opioid-induced constipation – naloxegol
Inflammatory bowel disease – vedolizumab
Inflammatory bowel disease – vedolizumab
Obesity – lorcaserin
Obesity – lorcaserin
Drug approvals: more numerous but niche
Drug approvals: more numerous but niche
Irritable bowel syndrome – linaclotide
Irritable bowel syndrome – linaclotide
Short bowel syndrome – teduglutide
Short bowel syndrome – teduglutide
Gastroparesis – ulimorelin
Gastroparesis – ulimorelin